Drug Delivery through Blood-Brain Barrier (BBB)

The brain is shielded and segregated from the normal circulation by a highly adequate blood-brain barrier. This is characterised by relatively impermeable endothelial cells with tight junctions, enzymatic activity and active efflux transport systems. Therefore the blood-brain barrier is layout to allow discriminatory carrier of molecules that are important for brain function. This builds a extensive protest for the treatment of central nervous system diseases compelling therapeutic levels of drug to get into the brain. Some small lipophilic drugs diffuse across the blood-brain barrier- sufficiently well to be efficacious. However, many potentially useful drugs are excluded.


    Related Conference of Drug Delivery through Blood-Brain Barrier (BBB)

    March 18-19, 2024

    20th International Conference on Cancer Research

    Zurich, Switzerland
    April 24-25, 2024

    33rd Neonatology and Primary Care Congress

    Paris, France
    April 30-30, 2024

    14th International Conference on Womens Health and Cancer Cure

    Amsterdam, Netherlands
    July 25-26, 2024

    20th World Summit on Blockchain Technology

    Amsterdam, Netherlands
    August 20-21, 2024

    11th World Summit on Epilepsy and Bipolar Disorders

    Montreal, Canada

    Drug Delivery through Blood-Brain Barrier (BBB) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in